Farther Finance Advisors
LENZ icon

Farther Finance Advisors’s LENZ Therapeutics LENZ Stock Holding History

Farther Finance Advisors’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$972 Sell
253
-342
-57% -$1.7K ﹤0.01% 5595
2026
Q2 		$3.38K Buy
595
+258
+77% +$2.08K ﹤0.01% 4979
2026
Q1 		$3.15K Sell
337
-159
-32% -$2.23K ﹤0.01% 4715
2025
Q4 		$7.94K Buy
496
+356
+254% +$10.4K ﹤0.01% 4062
2025
Q3 		$6.52K Buy
+140
New +$5.15K ﹤0.01% 3647

Other funds holding LENZ

GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Farther Finance Advisors's LENZ Position: Q3 2026 in Review

Farther Finance Advisors reduced its LENZ Therapeutics (LENZ) stake by 57% in Q3 2026, selling an estimated $1.7K and leaving 253 shares worth $972. The position accounts for ﹤0.01% of the portfolio, ranked #5595.

Farther Finance Advisors first reported a position in LENZ in Q3 2025 and has held it in 5 quarters since. The position peaked at $7.94K in Q4 2025. 4 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

  • Farther Finance Advisors held 253 shares of LENZ Therapeutics worth $972 as of Q3 2026.
  • Farther Finance Advisors sold 342 LENZ Therapeutics shares in Q3 2026, an estimated $1.7K.
  • LENZ Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5595 holding.
  • Farther Finance Advisors first reported a position in LENZ Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Farther Finance Advisors's LENZ Therapeutics position peaked at $7.94K in Q4 2025.
  • 4 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.